AIM To judge whether trapping vascular endothelial development aspect A (VEGF-A) would suppress angiogenesis and irritation in dry eyes corneas within a murine corneal suture model. II (dexamethasone, 5 mg/mL, 15 L, 12 eye), and subgroup III [phosphate-buffered saline (PBS), 15 L, 12 eye], for a complete of 6 experimental subgroups (Body 1). Open up… Continue reading AIM To judge whether trapping vascular endothelial development aspect A (VEGF-A)